S-Nitrosoglutathione Alters Fibrin Architecture 37. Baradet TC, Haselgrove JC, Weisel JW (1995) Three-dimensional reconstruc- tion of fibrin clot networks from stereoscopic intermediate voltage electron microscope images and analysis of branching. Biophys J 68: 1551–1560. 38. Marchi RC, Meyer MH, de Bosch NB, Arocha-Pinango CL, Weisel JW (2004) A novel mutation (deletion of Aalpha-Asn 80) in an abnormal fibrinogen: fibrinogen Caracas VI. Consequences of disruption of the coiled coil for the polymerization of fibrin: peculiar clot structure and diminished stiffness of the clot. Blood Coagul Fibrinolysis 15: 559–567. 39. Shacter E, Williams JA, Levine RL (1995) Oxidative modification of fibrinogen inhibits thrombin-catalyzed clot formation. Free Radic Biol Med 18: 815–821. 40. Pawloski JR, Hess DT, Stamler JS (2001) Export by red blood cells of nitric oxide bioactivity. Nature 409: 622–626. 41. Allen BW, Stamler JS, Piantadosi CA (2009) Hemoglobin, nitric oxide and molecular mechanisms of hypoxic vasodilation. Trends Mol Med 15: 452–460. 42. Gkaliagkousi E, Ritter J, Ferro A (2007) Platelet-derived nitric oxide signaling and regulation. Circ Res 101: 654–662. 43. Stamler JS (2004) S-nitrosothiols in the blood: roles, amounts, and methods of analysis. Circ Res 94: 414–417. 44. Hogg N (2000) Biological chemistry and clinical potential of S-nitrosothiols. Free Radic Biol Med 28: 1478–1486. 45. Vorp DA, Lee PC, Wang DH, Makaroun MS, Nemoto EM, et al. (2001) Association of intraluminal thrombus in abdominal aortic aneurysm with local hypoxia and wall weakening. J Vasc Surg 34: 291–299. 46. Fontaine V, Jacob MP, Houard X, Rossignol P, Plissonnier D, et al. (2002) Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol 161: 1701–1710. 47. Gersh KC, Zaitsev S, Cines DB, Muzykantov V, Weisel JW (2011) Flow- dependent channel formation in clots by an erythrocyte-bound fibrinolytic agent. Blood 117: 4964–4967. 48. Cote HC, Lord ST, Pratt KP (1998) gamma-Chain dysfibrinogenemias: molecular structure-function relationships of naturally occurring mutations in the gamma chain of human fibrinogen. Blood 92: 2195–2212. 49. Weisel JW (2005) Fibrinogen and fibrin. Adv Protein Chem 70: 247–299. 50. Undas A, Ariens RA (2011) Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler Thromb Vasc Biol 31: e88–99. PLOS ONE | www.plosone.org 13 August 2012 | Volume 7 | Issue 8 | e43660